Potent Tool: Helicobacter pylori Treatment to Reduce the Risk of Both Gastric and Colorectal Cancers

J Clin Oncol. 2024 Jun 1;42(16):1865-1867. doi: 10.1200/JCO.24.00019. Epub 2024 Mar 1.

Authors

Julia Butt¹, Meira Epplein²

Affiliations

¹ Infections and Cancer Epidemiology Division, German Cancer Research Center (DKFZ), Heidelberg, Germany.
² Departments of Population Health Sciences and Medicine, Duke University, and Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, NC.

PMID: 38427926
DOI: 10.1200/JCO.24.00019

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use
Colorectal Neoplasms* / microbiology
Helicobacter Infections* / complications
Helicobacter Infections* / drug therapy
Helicobacter pylori* / drug effects
Humans
Stomach Neoplasms* / microbiology
Stomach Neoplasms* / prevention & control

Substances

Anti-Bacterial Agents